Abbott Reports Q3 Sales Growth, Raises Full-Year EPS Guidance
With the Q3 2022 reporting season underway, US-based medtech giant Abbott (NYSE: ABT) released its...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity
With the Q3 2022 reporting season underway, US-based medtech giant Abbott (NYSE: ABT) released its...